Drug
Biib132
Biib132: highest development phase Phase 1, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIIB132 NCT05160558 | Phase 1 | Spinocerebellar Ataxia Type 3 |
Latest
No recent events.
Follow Biib132 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.